These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 35195839)

  • 1. Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.
    Solis RN; Silverman DA; Birkeland AC
    Curr Treat Options Oncol; 2022 Feb; 23(2):254-267. PubMed ID: 35195839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments.
    Jayawickrama SM; Ranaweera PM; Pradeep RGGR; Jayasinghe YA; Senevirathna K; Hilmi AJ; Rajapakse RMG; Kanmodi KK; Jayasinghe RD
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2045. PubMed ID: 38522008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
    Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR
    Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic sequencing and precision medicine in head and neck cancers.
    Hoesli RC; Ludwig ML; Michmerhuizen NL; Rosko AJ; Spector ME; Brenner JC; Birkeland AC
    Eur J Surg Oncol; 2017 May; 43(5):884-892. PubMed ID: 28034498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized cancer vaccination in head and neck cancer.
    Shibata H; Zhou L; Xu N; Egloff AM; Uppaluri R
    Cancer Sci; 2021 Mar; 112(3):978-988. PubMed ID: 33368875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
    Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
    Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.
    Giefing M; Wierzbicka M; Szyfter K; Brenner JC; Braakhuis BJ; Brakenhoff RH; Bradford CR; Sorensen JA; Rinaldo A; Rodrigo JP; Takes RP; Ferlito A
    Eur J Cancer; 2016 Mar; 55():147-57. PubMed ID: 26851381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.
    Wilson HL; D'Agostino RB; Meegalla N; Petro R; Commander S; Topaloglu U; Zhang W; Porosnicu M
    Oncologist; 2021 Feb; 26(2):e279-e289. PubMed ID: 33098199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing massively parallel sequencing in personalized head and neck oncology.
    Jessri M; Farah CS
    J Dent Res; 2014 May; 93(5):437-44. PubMed ID: 24557572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
    Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in early diagnosis of head and neck cancer in precision medicine era].
    Min MK; Zhu MH; Zheng HL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 31(22):1770-1774. PubMed ID: 29798197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics and precision surgery for head and neck squamous cell carcinoma.
    Galmiche A; Saidak Z; Bouaoud J; Mirghani H; Page C; Dakpé S; Clatot F
    Cancer Lett; 2020 Jul; 481():45-54. PubMed ID: 32272147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
    Eder T; Hess AK; Konschak R; Stromberger C; Jöhrens K; Fleischer V; Hummel M; Balermpas P; von der Grün J; Linge A; Lohaus F; Krause M; Baumann M; Stuschke M; Zips D; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Budach V; Tinhofer I;
    Eur J Cancer; 2019 Jul; 116():67-76. PubMed ID: 31173964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma.
    Sumner W; Ray X; Sutton L; Rebibo D; Marincola F; Sanghvi P; Moiseenko V; Deichaite I
    J Transl Med; 2021 May; 19(1):212. PubMed ID: 34001187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the genomic landscape of head and neck cancers through next-generation sequencing.
    Rizzo G; Black M; Mymryk JS; Barrett JW; Nichols AC
    Oral Dis; 2015 Jan; 21(1):e11-24. PubMed ID: 24725020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma.
    Gong W; Xiao Y; Wei Z; Yuan Y; Qiu M; Sun C; Zeng X; Liang X; Feng M; Chen Q
    Oncotarget; 2017 Jan; 8(2):2141-2152. PubMed ID: 27924064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational profiles of head and neck squamous cell carcinomas based upon human papillomavirus status in the Veterans Affairs National Precision Oncology Program.
    Doerstling S; Winski D; Katsoulakis E; Agarwal P; Poonnen PJ; Snowdon JL; Jackson GP; Weeraratne D; Kelley MJ; Vashistha V
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):69-77. PubMed ID: 36117189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of next generation sequencing in head and neck squamous cell carcinomas: a review.
    Tabatabaeifar S; Kruse TA; Thomassen M; Larsen MJ; Sørensen JA
    Oral Oncol; 2014 Nov; 50(11):1035-40. PubMed ID: 25223596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline Pathogenic Variants in Squamous Cell Carcinoma of the Head and Neck.
    Drbohlavová T; Argalácsová S; Soukupová J; Vočka M
    Folia Biol (Praha); 2023; 69(4):107-115. PubMed ID: 38410968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study.
    Rapado-González Ó; Brea-Iglesias J; Rodríguez-Casanova A; Bao-Caamano A; López-Cedrún JL; Triana-Martínez G; Díaz-Peña R; Santos MA; López-López R; Muinelo-Romay L; Martínez-Fernández M; Díaz-Lagares Á; Suárez-Cunqueiro MM
    Cancer Med; 2023 Mar; 12(6):6615-6622. PubMed ID: 36420687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.